An Insight into the Immunomodulatory Effects of Probiotics in the Prevention of COVID-19 Disease

Abstract

The coronavirus pandemic hit the world with different variants of SARS-CoV-2; reliable therapeutics are needed every hour to control and minimize the infection. To date, the way to menace the chaos of post-Covid infection is not confined rationally. Researchers are still on their way to the progression of an efficient way to eradicate the disease. However, to prevent it from causing infection post-entry into the body, there have been a few strategies to maintain and boost the immune system. At the onset of infection when no antiviral therapeutics were available, convalescent plasma therapies as a proposed mechanism were adapted to treat the post-Covid infection. Researchers have formulated the administration of different types of vaccines based on attenuated or inactivated nucleic acids or subunits after approval from the FDA and still continue to find the best reliable vaccines for better enhancement in inducing immunogenicity of the immune system to fight against the disease. The covid-19 infection affects the gut and lung axis and there has been dysbiosis of microbiota which leads to cause secondary infections. To accomplish homeostasis of essential microbiota in the body, the administration of different strains of probiotic bacteria has been one way to induce immunogenicity and combat the disease.